Suscribirse

Implementing an antibiotic stewardship program to reduce the duration of antibiotics in community-acquired pneumonia: Experience in a French pediatric hospital - 08/04/25

Doi : 10.1016/j.arcped.2025.02.002 
Lise Martin Perceval a, , Matthieu Wargny b, Myriam Benhamida a, Morgane Dumortier c, Christèle Gras-Le Guen a, Dominique Navas d, Elise Launay a
a Nantes Université, CHU Nantes, Pôle Hospitalo-Universitaire 5: General Pediatrics Care Unit, F-44000 Nantes, France 
b Nantes Université, CHU Nantes, Pôle Hospitalo-Universitaire 11: Santé Publique, Clinique des données, INSERM, CIC 1413, F-44000 Nantes, France 
c General Pediatrics Care Unit, Saint-Nazaire Hospital, F-44600 Saint-Nazaire, France 
d Nantes Université, CHU Nantes, Pôle Hospitalo-Universitaire 1, Pharmacy Department, F-44000 Nantes, France 

Corresponding author at. General pediatrics care department, University Hospital of Nantes, 38 boulevard Jean Monnet, 44093 Nantes Cedex, France.General pediatrics care departmentUniversity Hospital of Nantes38 boulevard Jean MonnetNantes Cedex44093France
En prensa. Pruebas corregidas por el autor. Disponible en línea desde el Tuesday 08 April 2025
This article has been published in an issue click here to access

Abstract

Objective

This work used a before–after study to evaluate the impact of a multifaceted stewardship intervention on the recommended duration of antibiotic treatment (5 vs 10 days) for non-severe community-acquired pneumonia (CAP) in pediatrics.

Methods

Children under age 15 years and 3 months who consulted for CAP in the emergency care unit of Nantes University Hospital from November 2019 to January 2020 and from December 2020 to April 2021 were included. Before the second period, the updated protocol was presented at a local meeting, sent by e-mail, and added to the internal network; physicians’ knowledge was tested through clinical situations and answers to the questionnaire as well as pocket cards were distributed. The main outcome was the absolute and relative difference in prescription adequacy according to the recommended duration of antibiotic therapy (5 days) before and after the intervention.

Results

We included 134 children: 71 and 63 before and after the intervention respectively. The proportion of adequate duration of antibiotic therapy prescribed was increased: 27 (38.0 %) children in the “before” group versus 50 (79.4 %) in the “after” group (p < 0.0001). The prescription adequacy ratio (after/before) was 2.09 (95 %CI, 1.51–2.88). The mean treatment duration was significantly higher in the “before” than “after” group: 7.3 versus 5.7 days (p < 0.0001). A total of 155 days of treatment per 100 treated children was avoided. The proportion of correctly prescribed dosages was higher in the “after” than the “before” group: + 18 % (p = 0.03). The proportion of nasopharyngeal PCR tests performed was significantly higher after than before the intervention (p < 0.0001). Chest X-rays were performed in almost all children in both groups.

Conclusion

This multifaceted stewardship intervention demonstrated clinically and statistically significant results concerning the prescribed antibiotic therapy duration at individual and population levels and could be extended to other care centers and other situations.

El texto completo de este artículo está disponible en PDF.

Keywords : Community-acquired pneumonia, Pediatrics, Antibiotic stewardship program


Esquema


© 2025  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.